É. Bardet
About
É. Bardet is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology.
According to data from OpenAlex, É. Bardet has authored 81 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Otorhinolaryngology, 42 papers in Pulmonary and Respiratory Medicine and 40 papers in Oncology. Recurrent topics in É. Bardet's work include Head and Neck Cancer Studies (44 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Diagnosis and Treatment (14 papers). É. Bardet is often cited by papers focused on Head and Neck Cancer Studies (44 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Diagnosis and Treatment (14 papers). É. Bardet collaborates with scholars based in France, Belgium and Switzerland. É. Bardet's co-authors include G. Calais, P. Maingon, Laurent Mineur, Alexander Beny, Laurence Collette, Jean-François Bosset, A. Daban, Ljiljana Radošević-Jelić, Jean-Claude Ollier and M. Alfonsi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
In The Last Decade
É. Bardet
81 papers receiving 6.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| É. Bardet France | 27 | 4.4k | 4.3k | 2.6k | 2.2k | 560 | 81 | 6.7k | ||
| G. Calais France | 39 | 5.2k 1.2× | 5.1k 1.2× | 2.7k 1.0× | 2.5k 1.1× | 751 1.3× | 179 | 8.3k | ||
| Daniel T. T. Chua China | 40 | 2.8k 0.6× | 3.5k 0.8× | 4.6k 1.8× | 2.0k 0.9× | 374 0.7× | 96 | 6.2k | ||
| Julie A. Kish United States | 33 | 3.1k 0.7× | 3.7k 0.9× | 5.2k 2.0× | 2.5k 1.1× | 322 0.6× | 82 | 7.3k | ||
| D. Peiffert France | 35 | 1.9k 0.4× | 3.6k 0.9× | 967 0.4× | 2.8k 1.3× | 585 1.0× | 258 | 5.9k | ||
| Anne Kirkpatrick Belgium | 14 | 1.9k 0.4× | 1.6k 0.4× | 1.9k 0.7× | 2.5k 1.1× | 270 0.5× | 16 | 4.4k | ||
| To‐Wai Leung China | 29 | 1.4k 0.3× | 1.7k 0.4× | 2.1k 0.8× | 1.2k 0.5× | 320 0.6× | 81 | 3.6k | ||
| F. Eschwège France | 30 | 1.4k 0.3× | 2.1k 0.5× | 1.3k 0.5× | 1.4k 0.6× | 388 0.7× | 106 | 3.3k | ||
| Kerstin Stenson United States | 37 | 1.9k 0.4× | 2.1k 0.5× | 2.8k 1.1× | 1.8k 0.8× | 291 0.5× | 133 | 4.7k | ||
| Hanne Sand Hansen Denmark | 32 | 1.3k 0.3× | 1.7k 0.4× | 1.5k 0.6× | 1.6k 0.7× | 323 0.6× | 71 | 3.6k | ||
| Aurélie Le Maître France | 16 | 1.2k 0.3× | 1.7k 0.4× | 2.7k 1.0× | 1.7k 0.8× | 373 0.7× | 38 | 3.8k |
Countries citing papers authored by É. Bardet
Since
Specialization
Citations
This map shows the geographic impact of É. Bardet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Bardet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Bardet more than expected).
Fields of papers citing papers by É. Bardet
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by É. Bardet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Bardet. The network helps show where É. Bardet may publish in the future.
Co-authorship network of co-authors of É. Bardet
This figure shows the co-authorship network connecting the top 25 collaborators of É. Bardet. A scholar is included among the top collaborators of É. Bardet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with É. Bardet. É. Bardet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Giraud, P, Philippe Giraud, M. Alfonsi, et al.. (2020). Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers. Cancers. 13(1). 57–57.
2.
Bibault, Jean‐Emmanuel, Sophie Dussart, P. Pommier, et al.. (2017). Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score–Weighted Analysis. International Journal of Radiation Oncology*Biology*Physics. 99(4). 929–937.
3.
Bosset, Jean-François, G. Calais, Laurent Mineur, et al.. (2014). Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. The Lancet Oncology. 15(2). 184–190.
4.
Piot, B, O. Malard, Christophe Ferron, et al.. (2014). Postoperative interstitial brachytherapy for resectable squamous cell carcinoma of the tongue. Brachytherapy. 14(1). 71–76.
5.
Espitalier, F., et al.. (2013). Partial laryngectomy as salvage surgery after radiotherapy: Oncological and functional outcomes and impact on quality of life. A retrospective study of 20 cases. European Annals of Otorhinolaryngology Head and Neck Diseases. 131(1). 15–19.
6.
Bardet, É., Laurent Martin, G. Calais, et al.. (2010). Subcutaneous Compared With Intravenous Administration of Amifostine in Patients With Head and Neck Cancer Receiving Radiotherapy: Final Results of the GORTEC2000-02 Phase III Randomized Trial. Journal of Clinical Oncology. 29(2). 127–133.
7.
Kérautret, J., et al.. (2010). Kératopathie centrale toxique et fibromyalgie : à propos d’un cas. Journal Français d Ophtalmologie. 33(7). 493.e1–493.e5.
8.
Rio, Emmanuel, et al.. (2009). Perioperative Interstitial Brachytherapy for Recurrent Keloid Scars. Plastic & Reconstructive Surgery. 124(1). 180e–181e.
9.
Janot, François, D. De Raucourt, E Benhamou, et al.. (2008). Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck Carcinoma. Journal of Clinical Oncology. 26(34). 5518–5523.
10.
Rio, E., É. Bardet, C. Ferron, et al.. (2006). Curiethérapie interstitielle des cancers cutanés des zones périorificielles de la face. Cancer/Radiothérapie. 10(3). 101–106.
11.
Delpon, G., et al.. (2006). Évaluation par l'imagerie embarquée de la précision de positionnement et de repositionnement en radiothérapie stéréotaxique fractionnée. Cancer/Radiothérapie. 10(6-7). 498–499.
12.
Janot, François, D. De Raucourt, Marine Castaing, et al.. (2006). Re-irradiation combined with chemotherapy after salvage surgery in head and neck carcinoma: A randomized trial from the GETTEC and GORTEC groups. Journal of Clinical Oncology. 24(18_suppl). 5508–5508.
13.
Rio, Emmanuel, É. Bardet, Christophe Ferron, et al.. (2005). Interstitial brachytherapy of periorificial skin carcinomas of the face: A retrospective study of 97 cases. International Journal of Radiation Oncology*Biology*Physics. 63(3). 753–757.
14.
Bardet, É., Laurent Martin, G. Calais, et al.. (2005). Subcutaneous (SbQ) Versus Intravenous (IV) Administration of Amifostine for Head and Neck (HN) Cancer Patients Receiving Radiotherapy (RT): Preliminary Results of the GORTEC 2000–02 Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 63. S127–S127.
15.
Bourhis, Jean, G. Calais, M. Lapeyre, et al.. (2004). Concomitant radiochemotherapy or accelerated radiotherapy: Analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Seminars in Oncology. 31(6). 822–826.
16.
Bosset, J.-F., G. Calais, A. Daban, et al.. (2003). Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. European Journal of Cancer. 40(2). 219–224.
17.
Bardet, É., Alain Rivière, Anne Charloux, et al.. (1997). A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: Final analysis. International Journal of Radiation Oncology*Biology*Physics. 38(1). 163–168.
18.
Bardet, É.. (1997). Effets tardifs des radiations ionisantes sur le testicule. Cancer/Radiothérapie. 1(6). 778–780.
19.
Nguyen, Tan Dat, Philippe Rougier, Michel Ducreux, et al.. (1997). Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I–II study. Radiotherapy and Oncology. 45(2). 129–132.
20.
Bardet, É., Jean‐Yves Douillard, A. Riviére, et al.. (1996). 2139 Chemotherapy followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): First interim analysis of a phase II trial. International Journal of Radiation Oncology*Biology*Physics. 36(1). 345–346.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by G. Calais Breakdown of academic impact, for papers by Daniel T. T. Chua Breakdown of academic impact, for papers by Julie A. Kish Breakdown of academic impact, for papers by D. Peiffert Breakdown of academic impact, for papers by Anne Kirkpatrick Breakdown of academic impact, for papers by To‐Wai Leung Breakdown of academic impact, for papers by F. Eschwège Breakdown of academic impact, for papers by Kerstin Stenson Breakdown of academic impact, for papers by Hanne Sand Hansen Breakdown of academic impact, for papers by Aurélie Le Maître